Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope
Drug Design, Development and Therapy · 2026-02 · Volume 20 · 1-21
DOI: 10.2147/dddt.s570831 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-02. Verfasst von Aditya Luhung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Alpha Particles, Beta Particles, Radioisotopes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
ORCID-Profile: Aliya Nur Hasanah
Zitieren
APA
Luhung, A., Hasanah, A. N., & Ramdhani, D. (2026). Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope. Drug Design, Development and Therapy, Volume 20, 1-21. https://doi.org/10.2147/dddt.s570831
Vancouver
Luhung A, Hasanah AN, Ramdhani D. Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope. Drug Design, Development and Therapy. 2026;Volume 20:1-21. doi:10.2147/dddt.s570831
BibTeX
@article{Luhung2026,
author = {Luhung, Aditya and Hasanah, Aliya Nur and Ramdhani, Danni},
title = {Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--21},
doi = {10.2147/dddt.s570831}
}
EUVIMED